These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15197520)

  • 1. Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years.
    Rembratt A; Graugaard-Jensen C; Senderovitz T; Norgaard JP; Djurhuus JC
    Eur J Clin Pharmacol; 2004 Aug; 60(6):397-402. PubMed ID: 15197520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and pharmacokinetics of desmopressin in elderly men.
    Hougaard C; Matthiesen TB; Rittig S; Djurhuus JC
    Scand J Urol Nephrol Suppl; 1997; 183():53-4. PubMed ID: 9165608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacokinetic and pharmacodynamic comparison of desmopressin administered as whole, chewed and crushed tablets, and as an oral solution.
    Argenti D; Ireland D; Heald DL
    J Urol; 2001 May; 165(5):1446-51. PubMed ID: 11342894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of 400 microg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect.
    Hvistendahl GM; Riis A; Nørgaard JP; Djurhuus JC
    BJU Int; 2005 Apr; 95(6):804-9. PubMed ID: 15794787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects.
    Rittig S; Jensen AR; Jensen KT; Pedersen EB
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):235-41. PubMed ID: 9579238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacokinetic and pharmacodynamic study of desmopressin: evaluating sex differences and the effect of pre-treatment with piroxicam, and further validation of an indirect response model.
    Odeberg JM; Callréus T; Lundin S; Roth EB; Höglund P
    J Pharm Pharmacol; 2004 Nov; 56(11):1389-98. PubMed ID: 15525445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in gastrointestinal motility influence the absorption of desmopressin.
    Callréus T; Lundahl J; Höglund P; Bengtsson P
    Eur J Clin Pharmacol; 1999 Jun; 55(4):305-9. PubMed ID: 10424324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and antidiuretic effect of high-dose desmopressin in patients with chronic renal failure.
    Ruzicka H; Björkman S; Lethagen S; Sterner G
    Pharmacol Toxicol; 2003 Mar; 92(3):137-42. PubMed ID: 12753429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations.
    Joukhadar C; Schenk B; Kaehler ST; Kollenz CJ; Bauer P; Müller M; Eichler HG
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):631-6. PubMed ID: 14564429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of pharmacodynamics and bioavailability of 2 different desmopressin nasal sprays.
    Eller N; Kollenz CJ; Hitzenberger G
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):139-45. PubMed ID: 9562229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect-response modeling of desmopressin at different levels of hydration.
    Callréus T; Odeberg J; Lundin S; Höglund P
    J Pharmacokinet Biopharm; 1999 Oct; 27(5):513-29. PubMed ID: 10948696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients.
    Agersø H; Seiding Larsen L; Riis A; Lövgren U; Karlsson MO; Senderovitz T
    Br J Clin Pharmacol; 2004 Oct; 58(4):352-8. PubMed ID: 15373927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiuresis: a new concept in managing female daytime urinary incontinence.
    Robinson D; Cardozo L; Akeson M; Hvistendahl G; Riis A; Norgaard JP
    BJU Int; 2004 May; 93(7):996-1000. PubMed ID: 15142150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and Pharmacodynamic Properties of a Micro-Dose Nasal Spray Formulation of Desmopressin (AV002) in Healthy Water-Loaded Subjects.
    Andersson KE; Longstreth J; Brucker BM; Campeau L; Cheng L; Francis L; Fein S
    Pharm Res; 2019 Apr; 36(6):92. PubMed ID: 31037429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma pharmacokinetics of desmopressin following sublingual administration: an exploratory dose-escalation study in healthy male volunteers.
    Steiner IM; Kaehler ST; Sauermann R; Rinösl H; Müller M; Joukhadar C
    Int J Clin Pharmacol Ther; 2006 Apr; 44(4):172-9. PubMed ID: 16625986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men.
    Mattiasson A; Abrams P; Van Kerrebroeck P; Walter S; Weiss J
    BJU Int; 2002 Jun; 89(9):855-62. PubMed ID: 12010228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmopressin tablet treatment: factors influencing gastrointestinal absorption.
    Rittig S; Jensen AR; Jensen KT; Pedersen EB
    Scand J Urol Nephrol Suppl; 1997; 183():51-2. PubMed ID: 9165607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis.
    Vande Walle JG; Bogaert GA; Mattsson S; Schurmans T; Hoebeke P; Deboe V; Norgaard JP;
    BJU Int; 2006 Mar; 97(3):603-9. PubMed ID: 16469035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.
    De Guchtenaere A; Raes A; Vande Walle C; Hoebeke P; Van Laecke E; Donckerwolcke R; Vande Walle J
    J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.